Literature DB >> 17373732

Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma.

I Bergheim1, E Wolfgarten, E Bollschweiler, A-H Hölscher, C Bode, A Parlesak.   

Abstract

AIM: To investigate the role of cytochrome P450 (CYP) in the carcinogenesis of squamous-cell carcinoma (SCC) in human esophagus by determining expression patterns and protein levels of representative CYPs in esophageal tissue of patients with SCC and controls.
METHODS: mRNA expression of CYP2E1, CYP2C, CYP3A4, and CYP3A5 was determined using RT-PCR in both normal and malignant esophageal tissues of patients with untreated esophageal SCC (n = 21) and in controls (n = 10). Protein levels of CYP2E1, CYP2C8, CYP3A4, and CYP3A5 were measured by Western blot.
RESULTS: Within the group of SCC patients, mRNA expression of CYP 3A4 and CYP2C was significantly lower in malignant tissue (-39% and -74%, respectively, P < 0.05) than in normal tissue. Similar results were found in CYP3A4 protein levels. Between groups, CYP3A4, CYP3A5, and CYP2C8 protein concentration was significantly higher in non-malignant tissue of SCC patients (4.8-, 2.9-, and 1.9-fold elevation, P < 0.05) than in controls. In contrast, CYP2E1 protein levels were significantly higher in controls than in SCC patients (+46%, P < 0.05).
CONCLUSION: Significant differences exist in protein levels of certain CYPs in non-malignant esophageal tissue (e.g. CYP2C8, CYP3A4, CYP3A5, and CYP2E1) between SCC patients and healthy subjects and may contribute to the development of SCC in the esophagus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373732      PMCID: PMC4146886          DOI: 10.3748/wjg.v13.i7.997

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability.

Authors:  T A Kocarek; R C Zangar; R F Novak
Journal:  Arch Biochem Biophys       Date:  2000-04-01       Impact factor: 4.013

2.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.

Authors:  E Bollschweiler; E Wolfgarten; C Gutschow; A H Hölscher
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

3.  Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation.

Authors:  E Eliasson; I Johansson; M Ingelman-Sundberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Vitamin intake and risk of subtypes of esophageal cancer in Germany.

Authors:  Elfriede Bollschweiler; Eva Wolfgarten; Thomas Nowroth; Ursula Rosendahl; Stefan P Mönig; Arnulf H Hölscher
Journal:  J Cancer Res Clin Oncol       Date:  2002-09-24       Impact factor: 4.553

5.  The paradoxical effect of acetaminophen on CYP3A4 activity and content in transfected HepG2 cells.

Authors:  D E Feierman; Z Melnikov; J Zhang
Journal:  Arch Biochem Biophys       Date:  2002-02-01       Impact factor: 4.013

6.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

Review 7.  Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts.

Authors:  Xinxin Ding; Laurence S Kaminsky
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

8.  Molecular biology of esophageal cancer.

Authors:  R Metzger; P M Schneider; U Warnecke-Eberz; J Brabender; A H Hölscher
Journal:  Onkologie       Date:  2004-04

Review 9.  Mechanisms of esophageal cancer development in Brazilians.

Authors:  Luis Felipe Ribeiro Pinto; Ana Maria Teixeira Rossini; Rodolpho Mattos Albano; Israel Felzenszwalb; Claudia Victoria de Moura Gallo; Rodolfo Acatuassú Nunes; Nelson Adami Andreollo
Journal:  Mutat Res       Date:  2003-11       Impact factor: 2.433

10.  Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.

Authors:  Ina Bergheim; Christiane Bode; Alexandr Parlesak
Journal:  BMC Gastroenterol       Date:  2005-11-10       Impact factor: 3.067

View more
  11 in total

1.  Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males.

Authors:  Yan-Mei Guo; Qin Wang; Yan-Zhen Liu; Huei-Min Chen; Zhi Qi; Qing-Hong Guo
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

2.  CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Authors:  Gulzar Ahmad Bhat; Idrees Ayoub Shah; Muzamil Ashraf Makhdoomi; Beenish Iqbal; Rumaisa Rafiq; Sumaiya Nabi; Akbar Masood; Mohd Maqbool Lone; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2014-02-08

3.  Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.

Authors:  Feng-Feng Gong; Shan-Shan Lu; Cai-Yun Hu; Zhen-Zhong Qian; Fang Feng; Yi-Le Wu; Hui-Yun Yang; Ye-Huan Sun
Journal:  Tumour Biol       Date:  2014-07-22

Review 4.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

5.  Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk.

Authors:  Nathália Moreno Cury; Anelise Russo; Ana Lívia Silva Galbiatti; Mariângela Torreglosa Ruiz; Luiz Sérgio Raposo; José Victor Maniglia; Erika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2011-05-18       Impact factor: 2.316

6.  CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.

Authors:  Elisa M Noll; Christian Eisen; Albrecht Stenzinger; Elisa Espinet; Alexander Muckenhuber; Corinna Klein; Vanessa Vogel; Bernd Klaus; Wiebke Nadler; Christoph Rösli; Christian Lutz; Michael Kulke; Jan Engelhardt; Franziska M Zickgraf; Octavio Espinosa; Matthias Schlesner; Xiaoqi Jiang; Annette Kopp-Schneider; Peter Neuhaus; Marcus Bahra; Bruno V Sinn; Roland Eils; Nathalia A Giese; Thilo Hackert; Oliver Strobel; Jens Werner; Markus W Büchler; Wilko Weichert; Andreas Trumpp; Martin R Sprick
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

Review 7.  Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review.

Authors:  Gabriel Kigen; Naftali Busakhala; Zipporah Kamuren; Hillary Rono; Wilfred Kimalat; Evangeline Njiru
Journal:  Infect Agent Cancer       Date:  2017-11-03       Impact factor: 2.965

8.  Identification of crucial miRNAs and genes in esophageal squamous cell carcinoma by miRNA-mRNA integrated analysis.

Authors:  Xiaowu Zhong; Guangcheng Huang; Qiang Ma; Hebin Liao; Chang Liu; Wenjie Pu; Lei Xu; Yan Cai; Xiaolan Guo
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 9.  Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers.

Authors:  Nataliya Pidkovka; Olena Rachkevych; Abbes Belkhiri
Journal:  Oncotarget       Date:  2021-02-16

10.  The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.

Authors:  Xiangkun Wang; Tingdong Yu; Xiwen Liao; Chengkun Yang; Chuangye Han; Guangzhi Zhu; Ketuan Huang; Long Yu; Wei Qin; Hao Su; Xiaoguang Liu; Tao Peng
Journal:  Cancer Med       Date:  2018-02-26       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.